![]() |
![]() |
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
(51) | INT.CL. | A61P 7/06 | (2018.01) |
C07D 207/08 | (2006.01) | ||
C07D 207/26 | (2006.01) | ||
C07D 211/22 | (2013.01) | ||
C07D 401/04 | (2013.01) | ||
C07D 211/22 | (2006.01) | ||
C07D 213/48 | (2013.01) | ||
C07D 211/76 | (2006.01) | ||
C07D 213/48 | (2006.01) | ||
C07D 207/26 | (2013.01) | ||
C07D 223/04 | (2006.01) | ||
C07D 265/30 | (2013.01) | ||
C07D 265/30 | (2006.01) | ||
C07D 405/04 | (2013.01) | ||
C07D 279/12 | (2006.01) | ||
C07D 417/04 | (2013.01) | ||
C07D 307/46 | (2006.01) | ||
C07D 413/04 | (2013.01) | ||
C07D 401/04 | (2006.01) | ||
C07D 307/46 | (2013.01) | ||
C07D 401/06 | (2006.01) | ||
C07D 401/06 | (2013.01) | ||
C07D 405/04 | (2006.01) | ||
C07D 223/04 | (2013.01) | ||
C07D 405/12 | (2006.01) | ||
C07D 405/12 | (2013.01) | ||
C07D 207/08 | (2013.01) | ||
C07D 413/04 | (2006.01) | ||
C07D 211/76 | (2013.01) | ||
C07D 417/04 | (2006.01) | ||
C07D 279/12 | (2013.01) | ||
A61P 7/06 | (2006.01) | ||
A61K 31/40 | (2006.01) |
(11) | Patento numeris | 3860975 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 19787545.3 |
Europos patento paraiškos padavimo data | 2019-09-30 | |
(97) | Europos patento paraiškos paskelbimo data | 2021-08-11 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2023-10-18 |
(46) | Apibrėžties vertimo paskelbimo data |
(86) | Numeris | PCT/US2019/053862 |
Data | 2019-09-30 |
(87) | Numeris | WO 2020/072377 |
Data | 2020-04-09 |
(30) | Numeris | Data | Šalis |
201862739757 P | 2018-10-01 | US | |
201962821311 P | 2019-03-20 | US |
(72) |
METCALF, Brian W. , US
LI, Zhe , US
XU, Qing , US
DUFU, Kobina N. , US
PARTRIDGE, James , US
SHAM, Hing , US
YU, Ming , US
|
(73) |
Global Blood Therapeutics, Inc. ,
181 Oyster Point Blvd., South San Francisco, CA 94080,
US
|
(54) | MODULATORS OF HEMOGLOBIN FOR THE TREATMENT OF SICKLE CELL DISEASE |
MODULATORS OF HEMOGLOBIN FOR THE TREATMENT OF SICKLE CELL DISEASE |